Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 193

    1.

    Effect of saralasin in hypertensive patients on chronic hemodialysis.

    Lifschitz MD, Kirschenbaum MA, Rosenblatt SG, Gibney R.

    Ann Intern Med. 1978 Jan;88(1):23-7.PMID: 619754 [PubMed - indexed for MEDLINE]Related articles

    2.

    The effect of an angiotensin antagonist (saralasin) on arterial pressure and plasma aldosterone in hemodialysis-resistant hypertensive patients.

    Mimran A, Shaldon S, Barjon P, Mion C.

    Clin Nephrol. 1978 Feb;9(2):63-7.PMID: 639368 [PubMed - indexed for MEDLINE]Related articles

    3.

    [Arterial hypertension and maintenance hemodialysis: effects of specific inhibition of angiotensin II by saralasin acetate]

    Mimran A, Deschodt G, Shaldon S, Barjon P, Mion C.

    Arch Mal Coeur Vaiss. 1978 Jul;71 Spec No:19-24. French. PMID: 101176 [PubMed - indexed for MEDLINE]Related articles

    4.

    Saralasin bolus test. Rapid screening procedure for renin-mediated hypertension.

    Marks LS, Maxwell MH, Kaufman JJ.

    Lancet. 1975 Oct 25;2(7939):784-7.PMID: 78152 [PubMed - indexed for MEDLINE]Related articles

    5.

    Pharmacokinetic and pharmacodynamic studies of infusions with [Sar 1, Val5, Ala8] angiotensin II (saralasin).

    Gless KH, Bönner G, Gram N, Mann JF, Helber A, Ganten D.

    Klin Wochenschr. 1978;56 Suppl 1:97-105.PMID: 732257 [PubMed - indexed for MEDLINE]Related articles

    6.

    Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin.

    Case DB, Wallace JM, Keim HJ, Weber MA, Drayer JI, White RP, Sealey JE, Laragh JH.

    Am J Med. 1976 Nov;61(5):790-6.PMID: 185903 [PubMed - indexed for MEDLINE]Related articles

    7.

    Detection of renovascular hypertension with angiotensin II blockade.

    Baer L, Parra-Carrilo JZ, Radichevich I, Williams GS.

    Ann Intern Med. 1977 Mar;86(3):257-60.PMID: 842983 [PubMed - indexed for MEDLINE]Related articles

    8.

    [Effect of the angiotensin antagonist saralasin on blood pressure and hemodynamics in patients with terminal renal insufficiency]

    Tuma J, Beckerhoff R, Záruba K, Furrer J, Vetter W.

    Schweiz Med Wochenschr. 1977 May 21;107(20):704-9. German. PMID: 867013 [PubMed - indexed for MEDLINE]Related articles

    9.

    Plasma catecholamines and the pressor response to Sar1-Ala8-angiotensin II in man.

    McGrath BP, Ledingham JG, Benedict CR.

    Clin Sci Mol Med. 1977 Oct;53(4):341-8.PMID: 913058 [PubMed - indexed for MEDLINE]Related articles

    10.

    [Effect of saralasin on normal blood pressure and on reno-vascular hypertension (author's transl)]

    Beckerhoff R, Vetter W, Furrer J, Nussberger J, Schmied U, Siegenthaler W.

    Dtsch Med Wochenschr. 1976 Mar 12;101(11):398-401. German. PMID: 1253700 [PubMed - indexed for MEDLINE]Related articles

    11.

    Angiotensin II, plasma renin and sodium depletion as determinants of blood pressure response to saralasin in essential hypertension.

    Thananopavarn C, Golub MS, Eggena P, Barrett JD, Sambhi MP.

    Circulation. 1980 May;61(5):920-4.PMID: 6988103 [PubMed - indexed for MEDLINE]Related articles

    12.

    Pressor response to 1-sar-8-ala-angiotensin II (saralasin) in hypertensive subjects.

    Anderson GH Jr, Streeten DH, Dalakos TG.

    Circ Res. 1977 Mar;40(3):243-50.PMID: 837471 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Renin, blood volume and response to saralasin in patients on chronic haemodialysis: evidence against volume- and renin-'dependent' hypertension.

    McGrath BP, Ledingham JG.

    Clin Sci Mol Med. 1978 Mar;54(3):305-12. No abstract available. PMID: 630806 [PubMed - indexed for MEDLINE]Related articles

    14.

    Role of the renin-angiotensin system in post-transplantation hypertension in patients with multiple kidneys.

    Linas SL, Miller PD, McDonald KM, Stables DP, Katz F, Weil R, Schrier RW.

    N Engl J Med. 1978 Jun 29;298(26):1440-4.PMID: 349389 [PubMed - indexed for MEDLINE]Related articles

    15.

    Detection of renovascular hypertension: saralasin test versus renin determinations.

    Marks LS, Maxwell MH, Smith RB, Cahill PJ, Kaufman JJ.

    J Urol. 1976 Oct;116(4):406-9.PMID: 1053323 [PubMed - indexed for MEDLINE]Related articles

    16.

    Effects of the angiotensin II antagonist 1-sar-8-ala-angiotensin II in hypertension in man.

    Fagard R, Amery A, Lijnen P, Reybrouck T.

    Eur J Clin Invest. 1977 Dec;7(6):473-9.PMID: 415868 [PubMed - indexed for MEDLINE]Related articles

    17.

    Diuretic therapy and response of essential hypertension to saralasin.

    Anderson GH Jr, Dalakos TG, Elias A, Tomycz N, Streeten DH.

    Ann Intern Med. 1977 Aug;87(2):183-7.PMID: 889199 [PubMed - indexed for MEDLINE]Related articles

    18.

    The effects of saralasin, an angiotensin II antagonist, on blood pressure and the renin-angiotensin-aldosterone system in normal and hypertensive subjects.

    Brown JJ, Brown WC, Fraser R, Lever AF, Morton JJ, Robertson JI, Rosei EA, Trust PM.

    Aust N Z J Med. 1976 Aug;6(3 Suppl):48-52.PMID: 1071403 [PubMed - indexed for MEDLINE]Related articles

    19.

    Identification of angiotensinogenic hypertension in man using 1-sar-8-ala-angiotensin II (Saralasin, P-113).

    Streeten DH, Freiberg JM, Anderson GH, Dalakos TG.

    Circ Res. 1975 Jun;36(6 Suppl 1):125-32.PMID: 1132074 [PubMed - indexed for MEDLINE]Related articles

    20.

    The diagnostic and therapeutic uses of saralasin in renal transplant hypertension.

    Zawada ET Jr, Maxwell MH, Marks LS, Lee DB, Kaufman JJ.

    J Urol. 1980 Feb;123(2):148-52.PMID: 6986475 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data